Loading clinical trials...

Reliability of Longshi Scale With Remote Assessment | Clinical Trials | Clareo Health

UNKNOWN

Reliability of Longshi Scale With Remote Assessment

Reliability of Longshi Scale With Remote Assessment of Smartphone Video Calls for Stroke Patients'Activities of Daily Living

NCT05395637•Shenzhen Second People's Hospital

View on ClinicalTrials.gov

Summary

To explore the reliability of remote Longshi Scale assessment with smartphone video calls by comparing the consistency of remote assessment and bedside assessment, as well as the test-retest reliability of the remote assessment. The evaluation duration of these two methods was recorded and the level of satisfaction of patients and evaluators was investigated.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•a.Stroke survivors
•1. aged 18 and above;
•2. diagnosed with cerebral infraction or intracerebral hemorrhage;
•3. stroke onset2 weeks;
•4. stable vital signs (heart rate, blood pressure, respiratory rate, oxygen saturation and temperature);
•5. voluntary or guardian consent to participate in the study.
•b.Evaluators
•
•1. registered rehabilitation practitioner;
•2. experience in rehabilitation scientific research or education related work for more than two years

Exclusion Criteria

•a.Stroke survivors
•1. brain tumor, Parkinson's disease or active epilepsy within past three months;
•2. a history of mental illness such as mania or delirium;
•3. participation in any other clinical study. b.Evaluators
•
•1. unable to finish the training of Longshi Scale or use smartphones proficiently.

Locations (1)

Shenzhen Second People's Hospital

Shenzhen, Guangdong, China

Key Dates

Start Date

May 20, 2022

Primary Completion Date

May 25, 2022

Completion Date

May 30, 2022

Last Updated

May 27, 2022

Enrollment

129

ESTIMATED participants

Conditions

StrokeTelemedicine

Cerebellar Stimulation for Aphasia Rehabilitation

NCT05093673

Stroke

View study

RECRUITINGPHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants

NCT07371455

Ischemic Stroke

View study

RECRUITINGNA

Effects of Circuit Training Combining Different Types of Distal Robot-assisted and Task-oriented Therapy on Motor Control, Motor and Daily Functions, and Quality of Life After Stroke

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 27, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Reliability of Longshi Scale With Remote Assessment

Inclusion Criteria

Exclusion Criteria

Cerebellar Stimulation for Aphasia Rehabilitation

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants

Effects of Circuit Training Combining Different Types of Distal Robot-assisted and Task-oriented Therapy on Motor Control, Motor and Daily Functions, and Quality of Life After Stroke

Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours

Rapid Evacuation and Access of Cerebral Hemorrhage Trial

The CONFORM Pivotal Trial